Inside Health Policy digs into the nominee's past advocacy...

Trump's OIRA-Nominee Has Questioned Foundations Of Administrative State

/ April 21, 2017 at 11:55 AM
Neomi Rao, President Donald Trump's pick to lead the White House Office of Information and Regulatory Affairs, if confirmed would likely aggressively push regulatory reform throughout the government and potentially ratchet back on FDA's use of guidance documents, according to regulatory experts and Rao's past writings. The nominee has advocated strong presidential oversight of federal agencies, including independent agencies, as well as regulatory budgeting -- signaling reg reforms laid out early in Trump's administration would likely continue should Rao assume...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.